The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2015

Filed:

Sep. 12, 2008
Applicants:

Kyogo Itoh, Kurume, JP;

Shigeki Shichijo, Kurume, JP;

Akira Yamada, Kurume, JP;

Inventors:

Kyogo Itoh, Kurume, JP;

Shigeki Shichijo, Kurume, JP;

Akira Yamada, Kurume, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/00 (2006.01); C07K 14/005 (2006.01); A61K 39/005 (2006.01); C07K 7/06 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/005 (2013.01); C07K 7/06 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/57 (2013.01); C12N 2770/24222 (2013.01);
Abstract

The present invention provides a CTL inducer composition which comprises one or more peptides selected from the group consisting of the peptides of SEQ ID NOS: 1 to 27 in the Sequence Listing, and can be used for the treatment or prevention of cancer or a hepatitis C virus-related disease in two or more patient groups selected from the group consisting of an HLA-A2 positive patient group, an HLA-A24 positive patient group, an HLA-A26 positive patient group, and an HLA-A3 supertype positive patient group.


Find Patent Forward Citations

Loading…